You’re using an unsupported browser.

For the best experience browsing on FB Rice, we recommend using the latest version of Chrome, Firefox, Safari or Edge. This website also runs on mobile web browsers.

You can download supported browsers using one of these links:

To check what browser version you are using, visit What Is My Browser.

Ken Seidenman
Associate

Tel: +61 3 8618 4131

Location:

  • Melbourne

Ken Seidenman is an associate in our Melbourne biotechnology team.

He has broad technical expertise in molecular biology, neuroscience, stem cells, drug discovery platforms, antibodies, small molecule therapeutic methods and cancer therapeutics. Ken is also a registered US Patent Agent. Having worked in a number of leading US law firms, Ken’s skills include preparation, prosecution and strategic counselling for biotechnology patent portfolio growth, while also assisting clients with evaluating patent validity, freedom to operate and due diligence matters.

Industry:

Technical Group:

Biotechnology

Read Ken's full bio

Education

  • Masters of Intellectual Property Law, The University of Melbourne
  • Post-Doctoral Fellow, Cold Spring Harbor Laboratory, USA
  • PhD in Neuroscience, Northwestern University, USA
  • Bachelor of Science in Biochemistry and Molecular Biology, University of Wisconsin-Madison, USA

Industry Expertise

  • Stem cells
  • CRISPR platform genome editing methods and compositions
  • Cancer immunotherapy compositions and methods
  • Small molecule drugs, antibodies, proteins, peptides, nucleic acids, and cell therapies for diagnostics including cancer and neurodegenerative disease biomarkers
  • Neuroscience, including compositions and devices for treatment of neurodegenerative or neurologic disorders

Professional Affiliations

  • Member - The Institute of Patent and Trade Mark Attorneys (IPTA)
  • Member - AusBiotech